Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2012

01-04-2012 | Editorial

Do Transcription Factors Hold the Key to Understanding the Development of Barrett’s Esophagus?

Author: Rebecca C. Fitzgerald

Published in: Digestive Diseases and Sciences | Issue 4/2012

Login to get access

Excerpt

Barrett’s esophagus is a complex metaplasia which can occur as a pure gastric or intestinal histopathological phenotype but more commonly occurs as a mosaic comprising gastric and intestinal forms. Intestinal metaplasia is typified by the presence of goblet cells seen on light microscopy. Some studies indicate that the chances of identifying goblet cells are related to the length of Barrett’s, location of the biopsies (more goblet cells in proximal esophagus), number of biopsies, patient age and gender, being more common in men [1]. Most interest has focussed on those patients with an endoscopically visible columnar lined epithelium containing intestinal metaplasia since this is the form most clearly associated with malignancy with an annual progression rate estimated to be in the region of 0.3–0.4% per annum [2, 3]. However, recent studies comparing goblet and non-goblet containing metaplastic epithelium have shown that both types demonstrate the same frequency of DNA content abnormalities [4, 5], suggesting that the gastric form is not entirely benign. …
Literature
1.
go back to reference Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett’s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007;102:1154–1161.PubMedCrossRef Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett’s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007;102:1154–1161.PubMedCrossRef
2.
3.
go back to reference Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049–1057.PubMedCrossRef Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049–1057.PubMedCrossRef
4.
go back to reference Odze RD. Barrett esophagus: histology and pathology for the clinician. Nat Rev Gastroenterol Hepatol. 2009;6:478–490.PubMedCrossRef Odze RD. Barrett esophagus: histology and pathology for the clinician. Nat Rev Gastroenterol Hepatol. 2009;6:478–490.PubMedCrossRef
5.
go back to reference Liu W, Hahn H, Odze RD, Goyal RK. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol. 2009;104:816–824.PubMedCrossRef Liu W, Hahn H, Odze RD, Goyal RK. Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol. 2009;104:816–824.PubMedCrossRef
6.
go back to reference Barbera M, Fitzgerald RC. Cellular origin of Barrett’s metaplasia and oesophageal stem cells. Biochem Soc Trans. 2010;38:370–373.PubMedCrossRef Barbera M, Fitzgerald RC. Cellular origin of Barrett’s metaplasia and oesophageal stem cells. Biochem Soc Trans. 2010;38:370–373.PubMedCrossRef
7.
go back to reference Wang X, Ouyang H, Yamamoto Y, et al. Residual embryonic cells as precursors of a Barrett’s-like metaplasia. Cell. 2011;145:1023–1035.PubMedCrossRef Wang X, Ouyang H, Yamamoto Y, et al. Residual embryonic cells as precursors of a Barrett’s-like metaplasia. Cell. 2011;145:1023–1035.PubMedCrossRef
8.
go back to reference Mutoh H, Hakamata Y, Sato K, et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun. 2002;294:470–479.PubMedCrossRef Mutoh H, Hakamata Y, Sato K, et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun. 2002;294:470–479.PubMedCrossRef
9.
go back to reference Wang DH, Clemons NJ, Miyashita T, et al. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett’s metaplasia. Gastroenterology. 2010;138:1810–1822.PubMedCrossRef Wang DH, Clemons NJ, Miyashita T, et al. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett’s metaplasia. Gastroenterology. 2010;138:1810–1822.PubMedCrossRef
10.
go back to reference Milano F, van Baal JW, Buttar NS, et al. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology. 2007;132:2412–2421.PubMedCrossRef Milano F, van Baal JW, Buttar NS, et al. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells. Gastroenterology. 2007;132:2412–2421.PubMedCrossRef
11.
go back to reference Kong J, Crissey MAS, Sepulveda AR, Lynch JP. Math1/Atoh1 contributes to intestinalisation of esophageal keratinocytes by inducing the expression of Muc2 and Keratin-20. Dig Dis Sci. 2011. doi:10.1007/s10620-011-1998-y. Kong J, Crissey MAS, Sepulveda AR, Lynch JP. Math1/Atoh1 contributes to intestinalisation of esophageal keratinocytes by inducing the expression of Muc2 and Keratin-20. Dig Dis Sci. 2011. doi:10.​1007/​s10620-011-1998-y.
12.
go back to reference Chen X, Qin R, Liu B, et al. Multilayered epithelium in a rat model and human Barrett’s esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol. 2008;8:1.PubMedCrossRef Chen X, Qin R, Liu B, et al. Multilayered epithelium in a rat model and human Barrett’s esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol. 2008;8:1.PubMedCrossRef
13.
go back to reference Hahn HP, Blount PL, Ayub K, et al. Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol. 2009;33:1006–1015.PubMedCrossRef Hahn HP, Blount PL, Ayub K, et al. Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol. 2009;33:1006–1015.PubMedCrossRef
14.
go back to reference Menke V, van Es JH, de Lau W, et al. Conversion of metaplastic Barrett’s epithelium into post-mitotic goblet cells by gamma-secretase inhibition. Dis Model Mech. 2010;3:104–110.PubMedCrossRef Menke V, van Es JH, de Lau W, et al. Conversion of metaplastic Barrett’s epithelium into post-mitotic goblet cells by gamma-secretase inhibition. Dis Model Mech. 2010;3:104–110.PubMedCrossRef
Metadata
Title
Do Transcription Factors Hold the Key to Understanding the Development of Barrett’s Esophagus?
Author
Rebecca C. Fitzgerald
Publication date
01-04-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2068-9

Other articles of this Issue 4/2012

Digestive Diseases and Sciences 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.